CSL
Bookmark
ShareCopied to clipboardCSL is a company. It is a public company in Melbourne, Australia. It was founded in 1916 and its current CEO is Paul F. McKenzie. It is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Melbourne
- country: Australia
- employees: 32,698 people
- revenues: 15.2B $
- company type: public
- sector: Health Care
- industry: Biotechnology
- foundation year: 1916
- CEO: Paul F. McKenzie
- CEO approval: 81 %
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about CSL:
Dataset of stocks from CSL:
CSL is one of the companies in Australia, companies in Biotechnology, companies in Health Care, companies in Melbourne and 3,456,808 companies in our database.
Talking Points
- CSL| Global Biotechnology Company
- CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
- Since our start in 1916, we have been driven by our promise to identify, develop and deliver innovations so our patients can live life to the fullest.
- Driven by our promise | Delivering on promises is what we do at CSL. More than a century ago, we made a promise to save lives and protect the health of people who were stricken with a range of serious and chronic medical conditions. Today, as a leading global biotechnology company, that same promise has never been stronger.
- CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
- CSL Vifor
- CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology.
- CSL Behring
- CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases.